The health ministry on Monday announced that a government panel on AEFI (Adverse Events Following Immunisation) has found 26 probable cases of bleeding and clotting after administration of the Covid-19 vaccine, Covishield. Source- Mint
The AEFI Committee said it had studied 498 (of 700) "serious and severe events" and found that only 26 had been reported as "potential thromboembolic events", referring to the potentially deadly form of a blood clot that could break loose and be carried by the bloodstream to obstruct another vessel.
"There is a very minuscule but definitive risk of thromboembolic events" after being vaccinated, the data indicated.
The panel also noted that Covishield - the AstraZeneca-Oxford University Covid-19 vaccine-associated with some studies to clotting issues - reported fewer than 0.61 cases per million doses distributed.
Number of Vaccines Administered
The panel said that as of 3 April, 75,435,381 vaccine doses had been administered (Covishield—68,650,819; Covaxin—6,784,562). Of these, 65,944,106 were first doses and 9,491,275 second dose.
The health ministry will issue counseling to Healthcare Workers and Vaccine Beneficiaries to encourage people to be aware of suspected thromboembolic symptoms occurring within 20 days after receiving any Covid vaccine (particularly Covishield) and report preferably to the health facility where the vaccine was administered :
pain in chest
pain in limbs/pain on pressing limbs or swelling in limbs (arm or calf)
multiple, pinhead size red spots or bruising of skin in an area beyond the injection site
persistent abdominal pain with or without vomiting
seizures in the absence of the previous history of seizures, with or without vomiting
severe and persistent headache with or without vomiting (in the absence of the previous history of migraine or chronic headache)
weakness or paralysis of limbs or any side of the body (including face)
persistent vomiting for no obvious reason
blurred vision or pain in the eyes, or having a double vision
change in mental status or having confusion or depressed level of consciousness
Any other symptom or health condition which concerns the recipient of the family